Empowering people affected by MS to live their best lives

(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({‘gtm.start’:
new Date().getTime(),event:’gtm.js’});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!=’dataLayer’?’&l=’+l:”;j.async=true;j.src=
‘https://www.googletagmanager.com/gtm.js?id=’+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,’script’,’dataLayer’,’GTM-WZZLD89′);

window.addEventListener(‘pushdatalayer’, function(event) {
const section = event.detail?.siteSection;
const subsection = event.detail?.siteSubsection;
const pageUrl = event.detail?.pageUrl;
const pageTitle = event.detail?.pageTitle;
const promptSelection = event.detail?.promptSelection;
const formId = event.detail?.formId;
const dataLayerEvent = {
event: event.detail.eventName,
eventCallback: function () {
document.dispatchEvent(new CustomEvent(‘postdatalayerpush’, {
bubbles: true,
composed: true,
detail: event.detail,
}));
},
};
if (section) {
dataLayerEvent[‘site_section’] = section;
}
if (subsection) {
dataLayerEvent[‘site_subsection’] = subsection;
}
if (pageUrl) {
dataLayerEvent[‘pageUrl’] = pageUrl;
}
if (pageTitle) {
dataLayerEvent[‘pageTitle’] = pageTitle;
}
if(promptSelection){
dataLayerEvent[‘promptSelection’] = promptSelection;
}
if(formId){
dataLayerEvent[‘form_ID’] = formId;
}
window.dataLayer = window.dataLayer || [];
window.dataLayer.push(dataLayerEvent);
});



document.addEventListener(‘checkcookie’, () => {
var hasCookie = document.cookie.split(‘;’)
.some((cookie) => cookie.trim().startsWith(‘CookieConsent=’));
document.dispatchEvent(new CustomEvent(‘hascookie’, { detail: hasCookie }));
});


SDGs, Targets, and Indicators:

1. SDG 3: Good Health and Well-being
– Target 3.4: By 2030, reduce by one-third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.
– Indicator 3.4.1: Mortality rate attributed to cardiovascular disease, cancer, diabetes, or chronic respiratory disease.

2. SDG 10: Reduced Inequalities
– Target 10.2: By 2030, empower and promote the social, economic, and political inclusion of all, irrespective of age, sex, disability, race, ethnicity, origin, religion, or economic or other status.
– Indicator 10.2.1: Proportion of people living below 50 percent of median income.

3. SDG 17: Partnerships for the Goals
– Target 17.17: Encourage and promote effective public, public-private, and civil society partnerships, building on the experience and resourcing strategies of partnerships.
– Indicator 17.17.1: Amount of United States dollars committed to public-private and civil society partnerships.

Table:

| SDGs | Targets | Indicators |
|——|———|————|
| SDG 3: Good Health and Well-being | Target 3.4: By 2030, reduce by one-third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being. | Indicator 3.4.1: Mortality rate attributed to cardiovascular disease, cancer, diabetes, or chronic respiratory disease. |
| SDG 10: Reduced Inequalities | Target 10.2: By 2030, empower and promote the social, economic, and political inclusion of all, irrespective of age, sex, disability, race, ethnicity, origin, religion, or economic or other status. | Indicator 10.2.1: Proportion of people living below 50 percent of median income. |
| SDG 17: Partnerships for the Goals | Target 17.17: Encourage and promote effective public, public-private, and civil society partnerships, building on the experience and resourcing strategies of partnerships. | Indicator 17.17.1: Amount of United States dollars committed to public-private and civil society partnerships. |

Explanation:

1. The article discusses the National Multiple Sclerosis Society’s vision of a world free of MS, which aligns with SDG 3: Good Health and Well-being. The target 3.4 aims to reduce premature mortality from non-communicable diseases, including chronic diseases like multiple sclerosis. The indicator 3.4.1 measures the mortality rate attributed to specific non-communicable diseases, which can be used to track progress in managing and treating MS.

2. The article mentions the importance of promoting social, economic, and political inclusion for people affected by MS. This relates to SDG 10: Reduced Inequalities, specifically target 10.2, which focuses on empowering and promoting the inclusion of all individuals, regardless of their health condition. The indicator 10.2.1 measures the proportion of people living below a certain income threshold, which can indicate the economic inequalities faced by individuals with MS.

3. The article highlights the National Multiple Sclerosis Society’s partnerships with various organizations and stakeholders to address the challenges faced by people with MS. This aligns with SDG 17: Partnerships for the Goals, particularly target 17.17, which encourages effective partnerships between different sectors to achieve sustainable development. The indicator 17.17.1 measures the financial commitment to these partnerships, reflecting the level of collaboration and resource allocation towards addressing MS-related issues.

Overall, the article addresses SDGs 3, 10, and 17, with specific targets and indicators that can be used to measure progress towards the identified goals.

Behold! This splendid article springs forth from the wellspring of knowledge, shaped by a wondrous proprietary AI technology that delved into a vast ocean of data, illuminating the path towards the Sustainable Development Goals. Remember that all rights are reserved by SDG Investors LLC, empowering us to champion progress together.

Source: nationalmssociety.org

Join us, as fellow seekers of change, on a transformative journey at https://sdgtalks.ai/welcome, where you can become a member and actively contribute to shaping a brighter future.